Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of a kind of barley aglycone and its derivatives for preventing and treating skin proliferative diseases

A technology of derivatives and aglycones, applied in the field of biomedicine, can solve the problems of low cure rate, inability to effectively prolong the remission period of patients, slow curative effect, etc., and achieve the effects of good safety, good application prospect and remarkable effect.

Active Publication Date: 2018-11-16
NORTHEAST NORMAL UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these drugs have many disadvantages: thinning the epidermis and dermis of the skin and causing toxic and side effects such as telangiectasia; they can only quickly control the symptoms of patients in the progressive stage, and cannot effectively prolong the remission period of patients; biological agents such as etanercept and inflixime are expensive
Traditional Chinese medicines have a long history of treating psoriasis, mainly including Tripterygium wilfordii, Kunming mountain crabapple, Qingdai pills, Yujin silver chips, Yin Xie Ling, Yin Xie Granules, etc. characteristics, but the curative effect is relatively slow, the cure rate is low, and the recurrence rate is high
Therefore, there is no drug with definite curative effect in the treatment of this disease by traditional Chinese and Western medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of a kind of barley aglycone and its derivatives for preventing and treating skin proliferative diseases
  • Application of a kind of barley aglycone and its derivatives for preventing and treating skin proliferative diseases
  • Application of a kind of barley aglycone and its derivatives for preventing and treating skin proliferative diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Effects of barley aglycone and its derivatives on the viability of human epidermal keratinocytes

[0046] Human epidermal keratinocytes HaCaT cells were seeded into 96-well plates and cultured at a cell density of 1.2×10 4 1 / ml, dosing after 12h, the drugs were all diluted with 1640 medium containing 3% FBS, and the negative group was used as a control with 1640 medium containing 3% FBS containing DMSO. The volume is 100 μl / well; after the cells are cultured in a 37°C incubator containing 5% CO2 for 44 hours, add 20 μl MTT (5 mg / ml) to each well and continue to culture for 4 hours; discard the supernatant, add 100 μl DMSO to each well, On the instrument, vibrate for 10 minutes, detect the OD value at 570nm, and calculate the inhibition rate, inhibition rate=(1-absorbance mean value of the experimental group / absorbance mean value of the control group)×100%; independent experiments were repeated more than three times, and the experimental data were all used IC5...

Embodiment 2

[0050] Example 2 Detection of the Non-toxic Dose of Glycoside and Its Derivatives to Subcutaneous Connective Tissue Cells

[0051] Inoculate A9 subcutaneous connective tissue cells in 96-well plates with a cell density of 1.2×10 4 Individual / ml; Dosing after 12h, the drugs were all diluted with DMEM medium containing 3% FBS, and the negative group was used as a control with DMEM medium containing 3% FBS containing DMSO. The volume is 100 μl / well; after the cells were cultured for 44 hours in a 37°C incubator containing 5% CO2, 20 μl of MTT (5 mg / ml) was added to each well, and the culture was continued for 4 hours; On the standard instrument, vibrate for 10 minutes, and detect the OD value at 570nm; the independent experiment was repeated more than three times, and the experimental data were all calculated with SPSS statistical software. The results are shown in Table 2, which indicated that the aglycone and 579-1 to 579-27 derivatives had no obvious toxicity to subcutaneous ...

Embodiment 3

[0055] Example 3 Effects of barley aglycone and its derivatives on DNA synthesis in HaCaT cells

[0056] In order to further explore the effects of barley aglycone and its derivatives on the proliferation of HaCaT cells, we conducted a BrdU incorporation experiment. The HaCaT cells were treated with agluconin and its derivatives at a final concentration of 2 μg / ml, and the DMSO treatment group was used as a negative control. After adding the drug for different times, after adding BrdU for 6 hours, after a series of treatments, use a microplate reader at 450nm Check its OD value. see results figure 1 , the BrdU incorporation of HaCaT cells treated with saliva aglycone was lower than that of the DMSO control group at 12h, 24h, 36h and 48h, and reached a very significant level at 24h, indicating that saliva aglycone can inhibit HaCaT DNA synthesis of cells to inhibit their proliferation. Other derivatives also showed similar results.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses applications of periplogenin and a periplogenin derivative in preventing and treating skin proliferation diseases, and especially relates to applications of periplogenin and the periplogenin derivative in preparing a pharmaceutical composition used for preventing and treating skin proliferation diseases. The pharmaceutical composition can be made into capsule, tablet, emulsion, cream, gel, or ointment, and the weight content of periplogenin and the periplogenin derivative ranges from 1 to 99%. Periplogenin and the periplogenin derivative are capable of inhibiting proliferation of human skin abnormal proliferative cells, curative effect is excellent, and safety is high.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to the application of barley aglycone and its derivatives for preventing and treating skin hyperplasia diseases. Background technique [0002] Skin proliferative diseases refer to the benign proliferation of skin cells under the stimulation of internal and external factors, including psoriasis, common warts, periungual warts, seborrheic keratosis, flat warts, plantar warts, Melanous nevus, senile plaques, and hemangiomas were mainly located on the extremities, followed by the face and trunk, with an average of 3 skin lesions per case. Skin proliferative diseases generally do not cause serious harm to health, but they can cause pain, appearance damage, and even movement disorders, which cause great distress to patients (Joseph S.Mclaughlin, Adam B.Shafritz, MD.Cutaneous Warts[J ]. JHS, 2011, 36:342-344.). The age of onset of skin proliferative diseases is mainly dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/585A61K31/7048A61P17/00A61P17/06A61P17/12C07J19/00
CPCA61K31/585A61K31/7048C07J19/005
Inventor 鲍永利李玉新张文静杨晓光
Owner NORTHEAST NORMAL UNIVERSITY